Evidence map›Paper›PMID 41788734›Full record

ArticleFrontiers in medicine2026

Development and internal validation of a machine learning-based prediction model for pulmonary hypertension in COPD.

Ruoyu Wang, Jie Tan, Guangping Li, Zhenyu Pan, Huiling Guo, Wei Sun, Jing Wang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruoyu Wang *Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Jie Tan *School of Information Engineering, Guangdong University of Technology, Guangzhou, China.
Guangping LiSchool of Information Engineering, Guangdong University of Technology, Guangzhou, China.
Zhenyu PanDepartment of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Huiling GuoDepartment of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Wei SunDepartment of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Jing WangDepartment of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is frequently complicated by pulmonary hypertension (PH), which worsens prognosis, but early PH detection is limited by the invasiveness or suboptimal sensitivity of current diagnostic tools. Methods: In this retrospective study, we analyzed 523 hospitalized patients with COPD from Beijing Chaoyang Hospital. After standardized preprocessing and recursive feature elimination, 18 routinely available noninvasive clinical and physiological variables were retained as predictors. Eight machine-learning algorithms were trained to predict PH and compared using area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, F1 score, and decision-curve analysis; model interpretability was assessed with Shapley additive explanations (SHAP). Results: The CatBoost model showed the best discrimination (AUC 0.848; accuracy 0.830; sensitivity 0.758; specificity 0.866; F1 0.746). SHAP analysis identified right ventricular diameter, pulmonary artery diameter, arterial partial pressure of carbon dioxide, right atrial transverse diameter, and age as the most influential predictors. Conclusion: A CatBoost-based prediction model using readily obtainable noninvasive variables can estimate PH risk in COPD with good accuracy and provide transparent feature-level explanations, potentially facilitating earlier detection and risk-stratified management.

Indexed as

CatBoost algorithmchronic obstructive pulmonary diseaseclinical prediction modelfeature selectionmachine learningpulmonary hypertensionSHAP

Identifiers

PMID41788734
PMCPMC12956692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.